1. High Mobility Group AT-Hook 2 (HMGA2) Oncogenicity in Mesenchymal and Epithelial Neoplasia
   Uchenna Unachukwu et al, 2020, International Journal of Molecular Sciences CrossRef
2. Genome-wide association and expression quantitative trait loci studies identify multiple susceptibility loci for thyroid cancer
   Ho-Young Son et al, 2017, Nature Communications CrossRef
3. MDM2/X inhibitors under clinical evaluation: perspectives for the management of hematological malignancies and pediatric cancer
   Veronica Tisato et al, 2017, Journal of Hematology & Oncology CrossRef
4. Depletion of three combined THOC5 mRNA export protein target genes synergistically induces human hepatocellular carcinoma cell death
   S Saran et al, 2016, Oncogene CrossRef
5. Vanished MDM2 amplification in multiple recurrences of an irradiated poorly differentiated sarcoma with amplified TRIO::TERT fusion gene
   Samantha Goffinet et al, 2023, Genes, Chromosomes and Cancer CrossRef
6. Identification of SETD2-NF1 fusion gene in a pediatric spindle cell tumor with the chromosomal translocation t(3;17)(p21;q12)
   Ioannis Panagopoulos et al, 2017, Oncology Reports CrossRef
7. Machine Learning–Supported Diagnosis of Small Blue Round Cell Sarcomas Using Targeted RNA Sequencing
   Lea D. Schlieben et al, 2024, The Journal of Molecular Diagnostics CrossRef
8. MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies
   Shomereeta Roy et al, 2020, Cancers CrossRef
9. Extensive analysis of 59 sarcoma‐related fusion genes identified pazopanib as a potential inhibitor to COL1A1‐PDGFB fusion gene
   Takeshi Hirose et al, 2023, Cancer Science CrossRef